Rybelsus, the first oral GLP-1 receptor agonist, has gained attention for its role in managing type 2 diabetes. This groundbreaking medication works by mimicking the actions of the glucagon-like peptide-1 (GLP-1), a hormone that naturally occurs in the body. By stimulating insulin secretion from the pancreas, Rybelsus helps lower blood…